Neurocrine Biosciences (NBIX) Reports Q3 Loss of $0.13
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $153.50 +0.51%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.13), versus ($0.43) reported last year.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
